• Login
    • Login
    Advanced Search
    View Item 
    •   AMREF IR Home
    • Research Papers
    • General - GEN
    • General - GEN
    • View Item
    •   AMREF IR Home
    • Research Papers
    • General - GEN
    • General - GEN
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Patient Retention in Antiretroviral Therapy Programs up to Three Years on Treatment in Sub-Saharan Africa, 2007-2009: Systematic Review: Patient Retention in Antiretroviral Therapy Programs

    Thumbnail
    View/Open
    Researcharti (281.2Kb)
    Publication Date
    2010-06
    Authors
    Fox, Matthew P
    Rosen, Sydney
    Type
    Article, Journal
    Item Usage Stats
    8
    views
    0
    downloads
    Metadata
    Show full item record
    Citation

    Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010 Jun;15 Suppl 1(s1):1-15. doi: 10.1111/j.1365-3156.2010.02508.x. PMID: 20586956; PMCID: PMC2948795.

    Abstract/Overview

    Objectives To estimate the proportion of all-cause adult patient attrition from antiretroviral therapy (ART) programs in service delivery settings in sub-Saharan Africa through 36 months on treatment. Methods We identified cohorts within Ovid Medline, ISI Web of Knowledge, Cochrane Database of Systematic Reviews and four conference abstract archives. We summarized retention rates from studies describing observational cohorts from sub-Saharan Africa reporting on adult HIV 1- infected patients initiating first-line three-drug ART. We estimated all-cause attrition rates for 6, 12, 18, 24, or 36 months after ART initiation including patients who died or were lost to follow-up (as defined by the author), but excluding transferred patients. Results We analysed 33 sources describing 39 cohorts and 226 307 patients. Patients were more likely to be female (median 65%) and had a median age at initiation of 37 (range 34–40). Median starting CD4 count was 109 cells/mm3. Loss to follow-up was the most common cause of attrition (59%), followed by death (41%). Median attrition at 12, 24 and 36 months was 22.6% (range 7%–45%), 25% (range 11%–32%) and 29.5% (range 13%–36.1%) respectively. After pooling data in a random-effects meta-analysis, retention declined from 86.1% at 6 months to 80.2% at 12 months, 76.8% at 24 months and 72.3% at 36 months. Adjusting for variable follow-up time in a sensitivity analysis, 24 month retention was 70.0% (range: 66.7%–73.3%), while 36 month retention was 64.6% (range: 57.5%–72.1%). Conclusions Our findings document the difficulties in retaining patients in care for lifelong treatment, and the progress being made in raising overall retention rates. Keywords: antiretroviral therapy, attrition, retention, sub-Saharan Africa, systematic review, human immuno-deficiency virus

    Subject/Keywords
    Antiretroviral therapy (ART); Systematic Reviews; HIV; Patient
    Publisher
    Blackwell Publishing Ltd.
    Permalink
    http://repository.amref.org/handle/123456789/214
    Collections
    • General - GEN [355]

    Amref International University. All rights reserved | Copyright © 2021 
    Contact Us | Send Feedback

     

     

    Quick Links
    Amref International UniversityAmref Health AfricaKLISC

    Browse

    All of AMREF IRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsType

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Amref International University. All rights reserved | Copyright © 2021 
    Contact Us | Send Feedback